News

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...
The FDA will no longer recommend annual COVID vaccinations for healthy people younger than 65. This means that if you are ...
U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...
FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...
The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it ...
But what are the new FDA COVID vaccine regulations ... As a result, he says that changing the requirements to get the vaccine is unlikely to have a big impact on the population.
The FDA has authorized Moderna's updated COVID-19 vaccine for people aged 65 and older and those aged 12 to 64 with ...
The U.S. Food and Drug Administration has approved Moderna's (MRNA.O), opens new tab next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first ...
CHENNAI: The US Food and Drug Administration (FDA) on Saturday officially approved Moderna’s next-generation COVID-19 vaccine for use in key high-risk populatio ...